These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27031855)

  • 1. Soluble tumour necrosis factor receptor type II and survival in colorectal cancer.
    Babic A; Shah SM; Song M; Wu K; Meyerhardt JA; Ogino S; Yuan C; Giovannucci EL; Chan AT; Stampfer MJ; Fuchs CS; Ng K
    Br J Cancer; 2016 Apr; 114(9):995-1002. PubMed ID: 27031855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
    Glossop JR; Dawes PT; Nixon NB; Mattey DL
    Arthritis Res Ther; 2005; 7(6):R1227-34. PubMed ID: 16277675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of soluble tumor necrosis factor-alpha receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes.
    Shai I; Schulze MB; Manson JE; Rexrode KM; Stampfer MJ; Mantzoros C; Hu FB
    Diabetes Care; 2005 Jun; 28(6):1376-82. PubMed ID: 15920055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the tumor necrosis factor receptor II (TNF-RII) gene polymorphism and sTNF-RII plasma levels in healthy controls and in rheumatoid arthritis.
    Tolusso B; Sacco S; Gremese E; La Torre G; Tomietto P; Ferraccioli GF
    Hum Immunol; 2004 Dec; 65(12):1420-6. PubMed ID: 15603867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults.
    Erikstrup C; Kallestrup P; Zinyama-Gutsire RB; Gomo E; Butterworth AE; Pedersen BK; Ostrowski SR; Gerstoft J; Ullum H
    AIDS; 2007 Nov; 21(17):2283-91. PubMed ID: 18090276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic determinants of circulating levels of tumor necrosis factor receptor II and their association with TNF-RII gene polymorphisms.
    Vistoropsky Y; Ermakov S; Toliat MR; Trofimov S; Altmüller J; Malkin I; Nürnberg P; Livshits G
    Cytokine; 2010 Jul; 51(1):28-34. PubMed ID: 20488723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor necrosis factor receptors sTNF-RI and sTNF-RII in advanced chronic heart failure].
    Nowak J; Rozentryt P; Szewczyk M; Gierlotka M; Duszańska A; Szyguła B; Wojnicz R; Hawranek M; Poloński L; Zembala M
    Pol Arch Med Wewn; 2002 Mar; 107(3):223-9. PubMed ID: 12107980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum levels and urinary excretion of soluble receptors for tumor necrosis factor (sTNF R) in patients with primary glomerulonephritis].
    Kacprzyk F
    Pol Arch Med Wewn; 2002 Mar; 107(3):215-21. PubMed ID: 12107979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients.
    Jabłońska E; Pietruska Z
    Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):449-53. PubMed ID: 9437501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V; Jirsa M; Zima T; Kalousová M; Bartunková J; Stejskalová A; Dostál C; Zabka J
    Med Sci Monit; 2002 Jan; 8(1):BR24-9. PubMed ID: 11782670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis.
    Fissolo N; Cantó E; Vidal-Jordana A; Castilló J; Montalban X; Comabella M
    J Neuroimmunol; 2014 Jun; 271(1-2):56-9. PubMed ID: 24794503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers.
    Keum N; Yuan C; Nishihara R; Zoltick E; Hamada T; Martinez Fernandez A; Zhang X; Hanyuda A; Liu L; Kosumi K; Nowak JA; Jhun I; Soong TR; Morikawa T; Tabung FK; Qian ZR; Fuchs CS; Meyerhardt JA; Chan AT; Ng K; Ogino S; Giovannucci EL; Wu K
    Int J Cancer; 2017 Jun; 140(12):2648-2656. PubMed ID: 28268248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum interleukin-18 and soluble tumour necrosis factor receptor 2 are associated with disease severity in patients with paracoccidioidomycosis.
    Corvino CL; Mamoni RL; Fagundes GZ; Blotta MH
    Clin Exp Immunol; 2007 Mar; 147(3):483-90. PubMed ID: 17302897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of soluble TNF receptor II (sTNF-RII), IL-1 receptor antagonist (IL-1ra), tumor load and hypermetabolism on malnutrition in children with acute leukemia.
    Schmid I; Schmitt M; Streiter M; Meilbeck R; Haas RJ; Stachel DK
    Eur J Med Res; 2005 Nov; 10(11):457-61. PubMed ID: 16354598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc Deficiency And sTNF-RII Are Associated With Worse COVID-19 Outcomes.
    Mouchati C; Durieux JC; Zisis SN; Tribout H; Scott S; Smith B; Labbato D; McComsey GA
    J Nutr; 2024 May; 154(5):1588-1595. PubMed ID: 38043624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
    Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
    BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. sTNF-RII: is it useful for the early diagnosis of rejection and for prognosis after renal transplantation?
    Diller R; Winde G; Kötting S; Senninger N; Dietl KH; Spiegel HU
    Transpl Int; 2002 Jul; 15(7):335-40. PubMed ID: 12122509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group.
    Girardin E; Roux-Lombard P; Grau GE; Suter P; Gallati H; Dayer JM
    Immunology; 1992 May; 76(1):20-3. PubMed ID: 1321092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma inflammatory cytokines and survival of pancreatic cancer patients.
    Babic A; Schnure N; Neupane NP; Zaman MM; Rifai N; Welch MW; Brais LK; Rubinson DA; Morales-Oyarvide V; Yuan C; Zhang S; Poole EM; Wolpin BM; Kulke MH; Barbie DA; Wong K; Fuchs CS; Ng K
    Clin Transl Gastroenterol; 2018 Apr; 9(4):145. PubMed ID: 29691365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of plasma inflammatory markers and risk of colorectal cancer in men.
    Song M; Wu K; Ogino S; Fuchs CS; Giovannucci EL; Chan AT
    Br J Cancer; 2013 May; 108(9):1891-8. PubMed ID: 23591192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.